DNAA Social Capital Suvretta Holdings Corp I - Ordinary Shares - Class A

About DNAA

Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. Its technologies are designed to directly target the physiology of the brain. The company was founded by W. Edward Martucci II and Adam Gazzaley in December 2020 and is headquartered in Boston, MA.
50

Neutral Sentiment

How do you feel about DNAA?

Advertisement|Remove ads.